文献速递乳腺癌放疗

乳腺癌区域淋巴结复发的三维定位分析

A 3-Dimensional Mapping Analysis of Regional Nodal Recurrences in Breast Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-10-24

本研究在单一癌症中心1998至2013年接受根治性手术、伴或不伴放疗的乳腺癌患者中,将153例患者的243处孤立淋巴结复发灶叠加到代表性轴位CT图像上,分析锁骨上、腋窝和内乳淋巴结的解剖分布模式及相关临床病理因素。结果显示,复发多位于腋窝(42%)、内乳(32.5%)和锁骨上(25.5%),RTOG或ESTRO临床靶区覆盖82%的复发灶,野外复发多位于锁骨上外侧和后方区域。内乳淋巴结复发与脉管侵犯和3级病变相关,且内乳复发者总生存劣于腋窝复发者(5年OS 59% vs 72%,P=.03)。

要点

  • RTOG或ESTRO临床靶区覆盖82%(198/243)的淋巴结复发灶,野外复发多位于锁骨上外侧和后方。
  • 内乳淋巴结复发与脉管侵犯(P=.001)及3级病变(P=.001)相关,锁骨上复发与3级病变相关(P=.02)。
  • 内乳淋巴结复发者5年总生存为59%,腋窝复发者为72%(P=.03)。

核心结论

  • 当代治疗下乳腺癌淋巴结复发中,锁骨上外侧和后方是当前勾画图谱未常规包含的独立复发部位。
  • 3级乳腺癌和脉管侵犯最常与锁骨上淋巴结复发相关;作者认为,对具有这些特征的患者,修改临床靶区以包含锁骨上外侧和后方可能是有依据的。

研究设计与样本

  • 单中心1998至2013年治疗的乳腺癌患者中识别淋巴结复发者,排除既往远处转移或无对应影像的淋巴结复发。
  • 共153例符合条件患者的243处淋巴结复发灶被叠加到代表性轴位CT图像上,并行多因素分析及Kaplan-Meier曲线分析。

主要发现

  • 243处淋巴结复发中,腋窝102处(42%)、内乳79处(32.5%)、锁骨上62处(25.5%)。
  • RTOG或ESTRO临床靶区覆盖198/243处(82%)复发灶;野外复发中RTOG为30/45(67%)、ESTRO为49/55(89%)位于锁骨上外侧和后方区域。
  • 接受锁骨上区域放疗的高危患者与未接受淋巴结放疗的低危患者相比,内侧锁骨上复发率相似,外侧锁骨上复发率更高(P=.009)。
  • 脉管侵犯与内乳淋巴结复发关联最强(P=.001);3级病变与内乳(P=.001)和锁骨上(P=.02)淋巴结复发均高度相关。
  • 内乳淋巴结复发者总生存显著劣于腋窝复发者,5年OS分别为59%与72%(P=.03)。

临床怎么用

  • 作者认为,对具有3级乳腺癌和脉管侵犯特征的乳腺癌患者,修改临床靶区以包含锁骨上外侧和后方可能是有依据的。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The primary goal was to map the anatomic pattern of isolated nodal recurrences (NR) in the supraclavicular (SCV), axillary, and internal mammary nodes (IMNs) in patients with breast cancer treated with curative-intent surgery with or without radiation therapy (RT). Secondary objectives were to assess clinical and pathologic factors associated with patterns of NR and survival rates. METHODS AND MATERIALS: Patients with NR after treatment at a single cancer center during 1998 to 2013 were identified. Patients with prior distant metastases or NR without correlative imaging were excluded. All NRs were overlaid onto representative axial computed tomographic images. Multivariable analysis was performed to identify clinical and pathologic characteristics associated with NR. Kaplan-Meier curves were generated to assess the rate of relapse by nodal region according to pathologic feature or radiation treatment status. RESULTS: The locations of 243 NRs among 153 eligible patients were mapped. The majority of NR occurred in the axilla (42%; 102/243), followed by the IMN (32.5%; 79/243) and the SCV (25.5%; 62/243). Radiation Therapy Oncology Group (RTOG) or European Society for Radiation therapy and Oncology (ESTRO) clinical target volume encompassed 82% (198/243) of NRs. The majority of out-of-field NRs were located in the lateral and posterior SCV region for both RTOG (67%; 30/45) and ESTRO (89%; 49/55) guidelines. The high-risk patients who received regional RT to the SCV relapsed at a similar rate in the medial, but a higher rate in lateral SCV (P = .009), compared with low-risk patients who received no nodal RT. Lymphovascular invasion most strongly associated with IMN NR (P = .001); grade 3 disease highly associated with both IMN (P = .001) and SCV NR (P = .02). The presence of an IMN NR portended for significantly inferior overall survival (OS), compared with an axillary NR, with a 5-year OS of 59% versus 72%, respectively (P = .03). CONCLUSIONS: In this 3-dimensional image-based analysis of NR patterns in breast cancer patients treated with contemporary therapies, the lateral and posterior SCV represented a distinct site of NR that is not routinely included within current breast cancer contouring atlases. Grade 3 breast cancer and LVI were most commonly associated with the development of NR in the SCV. Modifying the CTV to encompass the lateral and posterior SCV in patients with breast cancer with these features might be justified.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. DeSelm C, Yang TJ, Cahlon O, et al. A 3-Dimensional Mapping Analysis of Regional Nodal Recurrences in Breast Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 30367906. doi:10.1016/j.ijrobp.2018.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。